Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
8
×
clinical trials
8
×
deals
8
×
life sciences
national blog main
national top stories
roche
8
×
boston blog main
boston top stories
fda
investing
san francisco blog main
san francisco top stories
cancer
national
boston
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
takeda pharmaceutical
texas blog main
texas top stories
venture capital
vertex pharmaceuticals
wisconsin blog main
wisconsin top stories
amgen
bristol-myers squibb
What
drug
cancer
medicines
roundup
ahead
asco
bio
crispr
days
fda
focus
gene
research
roche
team
therapeutics
access
advanced
alliance
ambien
american
analytics
annual
approval
attendees
attention
biofourmis
biotech
blueprint
branded
bristol
buy
calls
camp’s
candidate
capacity
car
cash
caught
causing
Language
unset
Current search:
biotech
×
deals
×
roche
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More